Feb 7 (Reuters) - Arcam  ARCM.ST  
    * Q4 sales increased by 18% to 208.1 (176.0) MSEK 
    * Q4 operating income amounted to -29.1 (14.0) MSEK 
    * Says operating income and net sales for the period 
includes non-recurring costs of 44.8 (0) MSEK  
    * Arcam, Q4 - order intake amounted to 24 (29) systems 
    * Says our contract manufacturer DiSanto continues to be 
burdened by weak sales for implants made with traditional 
technology 
    * Says EBM business and contract manufacturing have been 
characterized by slow growth, while in metal powder 
manufacturing we have grown significantly  
    * Says "second half of the year was dominated by GE's tender 
which for us is a strong confirmation that the business that we 
have built together now becomes a major player in the additive 
manufacturing industry"  
    * Says "bidding process had an impact on our operations 
since management had less time to act in the market. Our EBM 
customers took a somewhat cautious position and we see that it 
takes longer to close new orders"  
 
Source text for Eikon:  ID:nWkr81bphY  
Further company coverage:  ARCM.ST  
 
 (Stockholm Newsroom) 
 ((stockholm.newsroom@thomsonreuters.com; +46 (0)8-700 10 10;))